BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR T-Cell Therapy. Zhang L, Gao Z, Pan H, Li R, et al. N Engl J Med 2025;392:2282-2284.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang L, Gao Z, Pan H, Li R, et al. BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR T-Cell Therapy. N Engl J Med 2025;392:2282-2284.
PMID: 40499177